NO20024755D0 - Metode - Google Patents

Metode

Info

Publication number
NO20024755D0
NO20024755D0 NO20024755A NO20024755A NO20024755D0 NO 20024755 D0 NO20024755 D0 NO 20024755D0 NO 20024755 A NO20024755 A NO 20024755A NO 20024755 A NO20024755 A NO 20024755A NO 20024755 D0 NO20024755 D0 NO 20024755D0
Authority
NO
Norway
Prior art keywords
methods
identification
compounds
relates
present
Prior art date
Application number
NO20024755A
Other languages
English (en)
Inventor
Henrik Rasmussen
Audun Tornes
Jonny Oestensen
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Priority to NO20024755A priority Critical patent/NO20024755D0/no
Publication of NO20024755D0 publication Critical patent/NO20024755D0/no
Priority to AU2003272154A priority patent/AU2003272154B2/en
Priority to ES03754316T priority patent/ES2278189T3/es
Priority to CNB2003801007915A priority patent/CN100506286C/zh
Priority to DE60310429T priority patent/DE60310429T2/de
Priority to AT03754316T priority patent/ATE347913T1/de
Priority to PCT/NO2003/000328 priority patent/WO2004030651A2/en
Priority to JP2004541342A priority patent/JP4579687B2/ja
Priority to US10/530,094 priority patent/US20060173339A1/en
Priority to EP03754316A priority patent/EP1549355B1/en
Priority to US14/467,152 priority patent/US9579405B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Semiconductor Lasers (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20024755A 2002-10-03 2002-10-03 Metode NO20024755D0 (no)

Priority Applications (11)

Application Number Priority Date Filing Date Title
NO20024755A NO20024755D0 (no) 2002-10-03 2002-10-03 Metode
EP03754316A EP1549355B1 (en) 2002-10-03 2003-10-01 Method for the identification of sentinel lymph nodes
DE60310429T DE60310429T2 (de) 2002-10-03 2003-10-01 Verfahren zur identifizierung von wächter-lymphknoten
ES03754316T ES2278189T3 (es) 2002-10-03 2003-10-01 Procedimiento para la identificacion de ganglios linfaticos centinela.
CNB2003801007915A CN100506286C (zh) 2002-10-03 2003-10-01 用于鉴定前哨淋巴结的方法、化合物和制剂
AU2003272154A AU2003272154B2 (en) 2002-10-03 2003-10-01 Method, compounds and preparations for the identification of sentinel lymph nodes
AT03754316T ATE347913T1 (de) 2002-10-03 2003-10-01 Verfahren zur identifizierung von wächter- lymphknoten
PCT/NO2003/000328 WO2004030651A2 (en) 2002-10-03 2003-10-01 Method, compounds and preparations for the identification of sentinel lymph nodes
JP2004541342A JP4579687B2 (ja) 2002-10-03 2003-10-01 センチネルリンパ節の同定のための方法、化合物及び製剤
US10/530,094 US20060173339A1 (en) 2002-10-03 2003-10-01 Method, compounds and preparations for the identification of sentinel lymph nodes
US14/467,152 US9579405B2 (en) 2002-10-03 2014-08-25 Method, compounds and preparations for the identification of sentinel lymph nodes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20024755A NO20024755D0 (no) 2002-10-03 2002-10-03 Metode

Publications (1)

Publication Number Publication Date
NO20024755D0 true NO20024755D0 (no) 2002-10-03

Family

ID=19914060

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024755A NO20024755D0 (no) 2002-10-03 2002-10-03 Metode

Country Status (10)

Country Link
US (2) US20060173339A1 (no)
EP (1) EP1549355B1 (no)
JP (1) JP4579687B2 (no)
CN (1) CN100506286C (no)
AT (1) ATE347913T1 (no)
AU (1) AU2003272154B2 (no)
DE (1) DE60310429T2 (no)
ES (1) ES2278189T3 (no)
NO (1) NO20024755D0 (no)
WO (1) WO2004030651A2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1655040A1 (en) * 2004-10-08 2006-05-10 Bracco Imaging, S.P.A. Contrast agent formulations for the visualization of the lymphatic system
JP4968473B2 (ja) * 2007-11-22 2012-07-04 キユーピー株式会社 気泡入り酸性水中油型乳化食品及びその製造方法
DE102008033021A1 (de) * 2008-07-14 2010-01-21 Siemens Aktiengesellschaft Verfahren und Vorrichtung zur Bilddarstellung eines interessierenden Untersuchungsbereichs im Rahmen einer medizinischen Untersuchung oder Behandlung
JP6297776B2 (ja) 2009-05-27 2018-03-20 セレクタ バイオサイエンシーズ インコーポレーテッドSelecta Biosciences,Inc. 免疫調節薬−高分子化合物
EP2575876B1 (en) 2010-05-26 2017-12-06 Selecta Biosciences, Inc. Multivalent synthetic nanocarrier vaccines
JPWO2012002387A1 (ja) * 2010-07-01 2013-08-29 国立大学法人信州大学 センチネルリンパ節描出剤
MX2014001142A (es) 2011-07-29 2014-02-27 Selecta Biosciences Inc Nanoportadores sinteticos que generan respuestas inmunitarias humorales y de linfocitos t citotoxicos (ctl).
JP2013135801A (ja) * 2011-12-28 2013-07-11 Shinshu Univ センチネルリンパ節内部を描出する画像診断装置及びその作動方法
JP2015521876A (ja) * 2012-06-28 2015-08-03 ビー−ケー メディカル エーピーエス 超音波イメージング

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114703A (en) 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
US5732704A (en) 1995-10-13 1998-03-31 Neoprobe Corporation Radiation based method locating and differentiating sentinel nodes
WO1997029783A1 (en) * 1996-02-19 1997-08-21 Nycomed Imaging A/S Improvements in or relating to contrast agents
ES2316157T3 (es) * 1996-08-02 2009-04-01 Ge Healthcare As Mejoras en o relativas a agentes de contraste.
US6331289B1 (en) * 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors
US6371904B1 (en) 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6444192B1 (en) 1999-02-05 2002-09-03 The Regents Of The University Of California Diagnostic imaging of lymph structures
WO2001012071A1 (en) * 1999-08-13 2001-02-22 Point Biomedical Corporation Microparticles useful as ultrasonic contrast agents and for lymphatic system
AU2003268105B2 (en) * 2002-08-16 2011-11-03 John Wayne Cancer Institute Molecular lymphatic mapping of sentinel lymph nodes

Also Published As

Publication number Publication date
ES2278189T3 (es) 2007-08-01
ATE347913T1 (de) 2007-01-15
JP4579687B2 (ja) 2010-11-10
CN1694732A (zh) 2005-11-09
US9579405B2 (en) 2017-02-28
US20140363381A1 (en) 2014-12-11
WO2004030651A3 (en) 2005-04-07
EP1549355B1 (en) 2006-12-13
EP1549355A2 (en) 2005-07-06
JP2006503861A (ja) 2006-02-02
AU2003272154B2 (en) 2007-08-02
CN100506286C (zh) 2009-07-01
AU2003272154A1 (en) 2004-04-23
US20060173339A1 (en) 2006-08-03
DE60310429D1 (de) 2007-01-25
WO2004030651A2 (en) 2004-04-15
DE60310429T2 (de) 2007-10-11

Similar Documents

Publication Publication Date Title
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
DE60007095T2 (de) Calanolide zur hemmung von btk
CY1110337T1 (el) Παρασκευη πρεγκαμπαλινης και σχετικων ενωσεων
ATE344029T1 (de) Behandlung von typ ii diabetes mit dipeptidyl- peptidase-iv-hemmern
NO20032788D0 (no) Modafinil-forbindelse og cyklodekstrinblandinger
FI20020176A (fi) Menetelmä ja reagenssipakkaus geneettisen yhtäläisyyden osoittamiseksi
NO20024755D0 (no) Metode
ECSP045466A (es) Inhibidores de la peptido-desformilasa
UY28148A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
ATE279068T1 (de) Anonymisierungsverfahren
ATE443044T1 (de) Tace inhibitoren
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
EA200600601A1 (ru) Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы
DE60326773D1 (de) Peptid-deformylase-hemmer
NO20025738D0 (no) Metode
ATE343390T1 (de) Kalzilytische verbindungen
EA200200798A1 (ru) Кальцилитические соединения
BR0112600A (pt) Compostos calcilìticos
EA200500878A1 (ru) Кальцилитические соединения
DE60331654D1 (de) Nicht-radioaktives Strontiummittel zur Behandlung von Krebs
NO20022896L (no) Substituerte 1- og 2-naftol mannich baser
IS7441A (is) Peptíðdeformýlasatálmar
DE50311665D1 (de) Guanidinophenylalanin-verbindungen als urokinase-inhibitoren